Fig. 1From: Trends in treatment patterns and survival outcomes in advanced non-small cell lung cancer: a Canadian population-based real-world analysisFirst-line A and second-line B treatments received by patients with advanced NSCLC in the pre– and post–I-O periods. Percentages for treatment categories are only displayed if > 1%. Abbreviations: 1L first line; 2L second line; I-O immuno-oncology; IQR interquartile range; NSCLC non-small cell lung cancer; NSQ non-squamous; SQ squamousBack to article page